Learning Objectives:

At the conclusion of this session, the participant should be able to:

  • Develop familiarity with pathophysiology, epidemiology and risk factors for SUD’s
  • Consider risk mitigation strategies available when controlled substances are prescribed
  • Appreciate the stigma around SUD’s and the need for careful, balanced, difficult conversations with patients

Speaker:

Margaret Jarvis, MD, Staff, Geisinger - has disclosed the following financial relationship:
  • American Society of Addiction Medicine - Board of Directors
  • Addiction Medicine Examination Subcommittee – Committee Member
  • American Board of Preventive Medicine – Committee Member
Session date: 
12/06/2023 - 12:00pm to 1:00pm EST
Location: 
Microsoft Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.